EPIDIOLEX, Continues

EPIDIOLEX Continues to Lead the Way in Cannabinoid-Based Epilepsy Treatment | DelveInsight

07.08.2025 - 18:06:27 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/epidiolex-continues-to-lead-the-way-in-cannabinoid-based-epilepsy-treatment--delveinsight-302443662.html

en | boerse | 67957752 |